Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000223604 | SCV000269899 | benign | not specified | 2014-11-24 | criteria provided, single submitter | clinical testing | Ile540Met in exon 28 of TRDN: This variant is not expected to have clinical sign ificance because it has been identified in 3.5% (86/2472) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs7771303). |
Prevention |
RCV000223604 | SCV000311374 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000223604 | SCV000525691 | benign | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV002517461 | SCV000559450 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618572 | SCV000735306 | benign | Cardiovascular phenotype | 2015-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001285326 | SCV001471737 | benign | Catecholaminergic polymorphic ventricular tachycardia 5 | 2023-08-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000223604 | SCV004812962 | likely benign | not specified | 2024-02-25 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000223604 | SCV001979158 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001729460 | SCV001979480 | likely benign | not provided | no assertion criteria provided | clinical testing |